Completed PHASE3 INTERVENTIONAL 1-arm NCT01955252

Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea (YESA-13)

Sponsor: Barcelona Institute for Global Health

Conditions Yaws

Updated 7 times since 2017 Last updated: Aug 25, 2017 Started: Mar 31, 2013 Primary completion: May 31, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01955252, this PHASE3 trial focuses on Yaws and remains completed. Sponsored by Barcelona Institute for Global Health, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Sep 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Sep 2017 [monthly]

Active Not Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Barcelona Institute for Global Health
Lihir Medical Centre
National Department of Health of Papua New Guinea
University of Washington
World Health Organization

Data source: Lihir Medical Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Londolovit, Papua New Guinea